Ketogenic DietNCT07838818
Effects of Short-term Adaptation to Ketogenic Diet on Endurance Trained Athletes
A study testing Ketogenic diet in people with Ketogenic Diet and Control Condition, run by University of Padova at 1 site in Italy.
Trial summary
Skeletal muscle glycogen is a major endogenous carbohydrate store and an important substrate for ATP resynthesis during exercise. Its utilization increases with exercise intensity and duration, and low muscle glycogen availability has long been associated with impaired endurance exercise capacity. Read more about this study
- Who is it for?
- Ages 18 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Ketogenic Diet, Control Condition
- What is being tested?
- Ketogenic diet
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 24 participants
- Where
- 1 siteItaly
- Study dates
- 1 Nov 2024to 1 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Male
- Age 18-40 yr,
- BMI: 18-25 kg/m^2,
- At least two years of endurance training experience
- a cycling volume of at least 150 km·week
- habitual consumption of a carbohydrate-based diet (>50% of total daily energy intake from carbohydrates)
Who cannot join
- Chronic diseases
- Acute inflammatory states
- Psychiatric disorders
- Recent (within 3 months) treatment with anabolic steroids or systemic corticosteroids
Trial locations and contacts
1 site in 1 country.
Italy1 site
Department of Biomedical Sciences, University of Padus
Padova, Italy, 10034
About this study
Official title: Glycogen Depletion, Nutritional Ketosis, and Exercise Fatigue: Novel Assessment Methods and Psychobiological Mechanisms
Skeletal muscle glycogen is a major endogenous carbohydrate store and an important substrate for ATP resynthesis during exercise. Its utilization increases with exercise intensity and duration, and low muscle glycogen availability has long been associated with impaired endurance exercise capacity. Beyond its role as a metabolic substrate, glycogen availability may influence excitation-contraction coupling and Ca²⁺ handling, providing multiple mechanisms through which carbohydrate availability can affect contractile function and fatigue.
Ketogenic diets (KD), characterized by severe carbohydrate restriction (<5% of energy intake), induce a profound redistribution of exercise metabolism. Reduced carbohydrate availability markedly increases fat oxidation while decreasing reliance on carbohydrate and muscle glycogen during exercise. This adaptation has frequently been interpreted as a glycogen-sparing mechanism that could extend endogenous carbohydrate availability during prolonged exercise. However, reduced glycogen utilization does not necessarily imply glycogen preservation, particularly when exercise begins with substantially lower muscle glycogen stores. Direct evidence quantifying muscle glycogen before and after a standardized exercise bout during ketogenic adaptation remains limited.
Read more
The marked shift toward lipid oxidation may also have consequences for exercise energetics. Fat oxidation provides less ATP per unit of oxygen consumed than carbohydrate oxidation, thereby increasing the oxygen requirement for a given rate of oxidative ATP resynthesis. This may become particularly relevant as exercise intensity and ATP demand increase, when carbohydrate-derived energy provision becomes progressively more important. Thus, ketogenic adaptation may reduce glycogen utilization while simultaneously increasing the oxygen cost of exercise and limiting the capacity to sustain higher exercise intensities. Nutritional ketosis may additionally influence exercise responses beyond skeletal muscle metabolism. KD markedly increases circulating β-hydroxybutyrate (βHB), which can be utilized as an oxidative substrate by peripheral tissues and crosses the blood-brain barrier, contributing to cerebral oxidative metabolism. Whether increased ketone availability modifies the cerebral response to exercise, and whether this relates to perceptual or exercise responses during carbohydrate restriction, remains unclear.
Accordingly, the specific aims are:
- To determine the effects of 10 days of ketogenic adaptation on skeletal muscle glycogen availability and utilization during standardized prolonged exercise. It is hypothesized that KD reduces resting muscle glycogen and attenuates exercise-induced glycogen utilization without preserving post-exercise glycogen availability.
- To determine the effects of ketogenic adaptation on substrate oxidation, exercise energetics, and exercise capacity. It is hypothesized that the shift toward greater lipid oxidation increases the oxygen cost of standardized submaximal exercise and impairs both prolonged exercise tolerance and subsequent high-intensity endurance capacity.
- To explore circulating substrate, perceptual, and cerebral responses to exercise during nutritional ketosis. Glucose, lactate, and βHB responses, together with prefrontal cortical oxygenation assessed by functional near-infrared spectroscopy (fNIRS), are examined to determine whether the pronounced peripheral metabolic adaptations are accompanied by detectable alterations in cerebral hemodynamic or perceptual responses.
The main hypothesis is that short-term ketogenic adaptation induces a rapid shift from carbohydrate- toward lipid-derived energy provision, but that reduced glycogen utilization does not preserve absolute skeletal muscle glycogen availability. It is further hypothesized that this metabolic redistribution increases the oxygen requirement of prolonged exercise and impairs exercise capacity, particularly as energetic demand increases.
- Conditions
- Ketogenic Diet, Control Condition
- Being tested
- Ketogenic diet, Control Diet
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ketogenic dietOther
KD (5% CHO, 2.0 g/kg/day protein)
Control DietOther
Control diet: 55% CHO, 2.0 g/kg/day protein
| Study group | Role | What they receive |
|---|---|---|
| KETOGENIC DIET (KD) | Experimental | will follow ketogenic diet during the intervention Receives: Other: Ketogenic diet |
| CONTROL DIET | Active comparator | will follow control diet (55% carbohydrate) during the intervention Receives: Other: Control Diet |
What is being measured
The primary outcome is the main question the study is designed to answer.
Skeletal muscle glycogen
Resting Skeletal muscle glycogen and skeletal muscle utilization during exercise
Measured: 10 days
Endurance performance
Overall exercise tolerance will be quantified as total exercise duration (min), defined as the combined duration of the 2-h submaximal exercise bout and the subsequent TTE. Subsequent high-intensity endurance capacity will be quantified separately as TTE duration (min) .
Measured: 10 days
Pre-frontal cortex hemodynamics and perceived fatigability during endurance exercise
Functional near-infrared spectroscopy (fNIRS) was used to evaluate prefrontal cortex hemodynamics during exercise + questionnaire ( ROF, Feeiling scale)
Measured: 10 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Sep 2026
- Study start1 Nov 2024
- Primary completion15 Oct 2026
- Study completion1 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Ketogenic DietStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 24 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Padova
- Sponsor type
- University, hospital or other
- Collaborators
- University of Bologna
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07838818
- Sponsor's protocol ID
- GLYCO-LAB
- Status last verified
- Sep 2026
- First submitted
- 18 Sep 2026
- Last updated
- 5 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 5 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Glycogen Depletion, Nutritional Ketosis, and Exercise Fatigue: Novel Assessment Methods and Psychobiological Mechanisms
- ClinicalTrials.gov ID
- NCT07838818
- Acronym / sponsor ID
- GLYCO-LAB
- Conditions
- Ketogenic Diet, Control Condition
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 24 participants (actual)
- Lead sponsor
- University of PadovaUniversity, hospital or other
- Collaborators
- University of Bologna
- Study start
- 1 Nov 2024 (actual)
- Primary completion
- 15 Oct 2026 (actual)
- Study completion
- 1 Nov 2026 (estimated)
- First posted
- 24 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Skeletal muscle glycogen is a major endogenous carbohydrate store and an important substrate for ATP resynthesis during exercise. Its utilization increases with exercise intensity and duration, and low muscle glycogen availability has long been associated with impaired endurance exercise capacity. Beyond its role as a metabolic substrate, glycogen availability may influence excitation-contraction coupling and Ca²⁺ handling, providing multiple mechanisms through which carbohydrate availability can affect contractile function and fatigue.
Ketogenic diets (KD), characterized by severe carbohydrate restriction (<5% of energy intake), induce a profound redistribution of exercise metabolism. Reduced carbohydrate availability markedly increases fat oxidation while decreasing reliance on carbohydrate and muscle glycogen during exercise. This adaptation has frequently been interpreted as a glycogen-sparing mechanism that could extend endogenous carbohydrate availability during prolonged exercise. However, reduced glycogen utilization does not necessarily imply glycogen preservation, particularly when exercise begins with substantially lower muscle glycogen stores. Direct evidence quantifying muscle glycogen before and after a standardized exercise bout during ketogenic adaptation remains limited.
The marked shift toward lipid oxidation may also have consequences for exercise energetics. Fat oxidation provides less ATP per unit of oxygen consumed than carbohydrate oxidation, thereby increasing the oxygen requirement for a given rate of oxidative ATP resynthesis. This may become particularly relevant as exercise intensity and ATP demand increase, when carbohydrate-derived energy provision becomes progressively more important. Thus, ketogenic adaptation may reduce glycogen utilization while simultaneously increasing the oxygen cost of exercise and limiting the capacity to sustain higher exercise intensities. Nutritional ketosis may additionally influence exercise responses beyond skeletal muscle metabolism. KD markedly increases circulating β-hydroxybutyrate (βHB), which can be utilized as an oxidative substrate by peripheral tissues and crosses the blood-brain barrier, contributing to cerebral oxidative metabolism. Whether increased ketone availability modifies the cerebral response to exercise, and whether this relates to perceptual or exercise responses during carbohydrate restriction, remains unclear.
Accordingly, the specific aims are:
- To determine the effects of 10 days of ketogenic adaptation on skeletal muscle glycogen availability and utilization during standardized prolonged exercise. It is hypothesized that KD reduces resting muscle glycogen and attenuates exercise-induced glycogen utilization without preserving post-exercise glycogen availability.
- To determine the effects of ketogenic adaptation on substrate oxidation, exercise energetics, and exercise capacity. It is hypothesized that the shift toward greater lipid oxidation increases the oxygen cost of standardized submaximal exercise and impairs both prolonged exercise tolerance and subsequent high-intensity endurance capacity.
- To explore circulating substrate, perceptual, and cerebral responses to exercise during nutritional ketosis. Glucose, lactate, and βHB responses, together with prefrontal cortical oxygenation assessed by functional near-infrared spectroscopy (fNIRS), are examined to determine whether the pronounced peripheral metabolic adaptations are accompanied by detectable alterations in cerebral hemodynamic or perceptual responses.
The main hypothesis is that short-term ketogenic adaptation induces a rapid shift from carbohydrate- toward lipid-derived energy provision, but that reduced glycogen utilization does not preserve absolute skeletal muscle glycogen availability. It is further hypothesized that this metabolic redistribution increases the oxygen requirement of prolonged exercise and impairs exercise capacity, particularly as energetic demand increases.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| KETOGENIC DIET (KD) | Experimental | Other: Ketogenic dietwill follow ketogenic diet during the intervention |
| CONTROL DIET | Active comparator | Other: Control Dietwill follow control diet (55% carbohydrate) during the intervention |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Male
- Age 18-40 yr,
- BMI: 18-25 kg/m^2,
- At least two years of endurance training experience
- a cycling volume of at least 150 km·week
Key exclusion criteria (4 listed)
- Chronic diseases
- Acute inflammatory states
- Psychiatric disorders
- Recent (within 3 months) treatment with anabolic steroids or systemic corticosteroids
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ketogenic dietKD (5% CHO, 2.0 g/kg/day protein) | Other | KETOGENIC DIET (KD) |
| Control DietControl diet: 55% CHO, 2.0 g/kg/day protein | Other | CONTROL DIET |
Primary outcome
Skeletal muscle glycogen
Time frame: 10 days
Resting Skeletal muscle glycogen and skeletal muscle utilization during exercise
Endurance performance
Time frame: 10 days
Overall exercise tolerance will be quantified as total exercise duration (min), defined as the combined duration of the 2-h submaximal exercise bout and the subsequent TTE. Subsequent high-intensity endurance capacity will be quantified separately as TTE duration (min) .
Pre-frontal cortex hemodynamics and perceived fatigability during endurance exercise
Time frame: 10 days
Functional near-infrared spectroscopy (fNIRS) was used to evaluate prefrontal cortex hemodynamics during exercise + questionnaire ( ROF, Feeiling scale)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Nov 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Ketogenic Diet
Not yet recruiting
Ketone Ester for Treatment Of Acute Heart Failure
Acute Heart Failure
Recruiting
Well-Formulated Ketogenic Diet Polycystic Kidney Disease
Polycystic Kidney Disease
Not yet recruiting
GLAD-KE GLioma Biomarker and Safety Assessment During Dietary Ketone Elevation Subtitle: A Surgical Biomarker Discovery Study of Ketogenic Therapy in Recurrent Glioma
Recurrent Glioma (Glioblastoma Multiforme)
Recruiting
Ketogenic Diet and Neuromodulation in Treatment Resistant Depression
Major Depressive Disorder (MDD), Treatment Resistant Depression (TRD)
Active, not recruiting
Metabolic and Inflammatory Outcomes of the Ketogenic Diet Comparing Saturated and Unsaturated Fat Sources
PreDiabetes, Diabetes Mellitus, Type 2
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Ketogenic diet in people with Ketogenic Diet and Control Condition, run by University of Padova at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Skeletal muscle glycogen (time frame: 10 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.